Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Other Accumulated Expenses (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Other Accumulated Expenses for 1 consecutive years, with $643000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Other Accumulated Expenses changed N/A to $643000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $643000.0, a N/A change, with the full-year FY2024 number at $643000.0, changed N/A from a year prior.
  • Other Accumulated Expenses was $643000.0 for Q4 2024 at Pyxis Oncology.
  • In the past five years, Other Accumulated Expenses ranged from a high of $643000.0 in Q4 2024 to a low of $643000.0 in Q4 2024.